Zydus Lifesciences receives US approval for generic HIV-1 drug
Image Credit: newsbytes
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (USFDA), to market its generic Darunavir tablets in the country. It is an antiviral medication essential for treating Human Immunodeficiency Virus (HIV-1) infection. As a protease inhibitor, Darunavir works by preventing HIV-1 from multiplying within the body, making it a vital component in HIV therapy.